← SynDRA

TIRBANIBULIN

SynDRA canonical compound SYN0020264 — structure-anchored drug synonym record

All known targets

• SRC
• TUBB
• LYN

Mechanisms of action (all sources)

• SRC inhibitor
• Tyrosine-protein kinase SRC inhibitor
• tubulin polymerization inhibitor
• tyrosine kinase inhibitor
• TUBB INHIBITOR

Drug classes

• Enzyme Inhibitors
• Microtubule Inhibitor

ATC classes

• D06B · CHEMOTHERAPEUTICS FOR TOPICAL USE

Cross-references

• PubChem CID: 23635314
• ChEMBL: CHEMBL571546
• DrugBank: DB06137
• ChEBI: 231702
• KEGG: D11691
• RxNorm: 2471078
• PDB: DN0
• Wikipedia: Tirbanibulin
• TTD: D02LJW
• LINCS BRD: BRD-K29968218

Synonyms

• tirbanibulin mesylate
• KX01
• KX-01
• KX2-391
• klisyri
• ALM-14789
• Tirbanibuline
• Tirbanibulina
• KX-2-391
• KX-2391
• KX2391
• Klisyri
• KX 01
• UNII-4V9848RS5G
• N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide
• CHEMBL571546
• 4V9848RS5G
• MLS006011272
• SCHEMBL153779
• GTPL7957
• DTXSID30237862
• MolPort-023-293-512
• HUNGUWOZPQBXGX-UHFFFAOYSA-N
• HMS3656J15
• EX-A2434
• BCP02845
• ZINC43152787
• s2700
• BDBM50303801
• AKOS027276392
• SB16619
• CS-0248
• KX2-391 (KX01)
• BCP9000828
• 2-Pyridineacetamide, 5-(4-(2-(4-morpholinyl)ethoxy)phenyl)-n-(phenylmethyl)-
• NCGC00346644-05
• NCGC00346644-01
• KX 2

Reported adverse events

• Application site pain
• Application site pruritus
• Erythema
• Swelling